Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients;Chemoprophylaxe bakterieller infektionskrankheiten in der pädiatrischen onkologie

Klinische Padiatrie

Volumn 213, Issue SUPPL. 1, 2001, Pages

  Simon, A ^a   Fleischhack, G ^a   Marklein, G ^a   Ritter, J ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antibacterial chemoprophylaxis; Pediatric oncology

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; NORFLOXACIN; PENICILLIN DERIVATIVE; PLACEBO; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BONE MARROW CELL; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER PATIENT; CHEMOPROPHYLAXIS; CHILDHOOD CANCER; DRUG EFFICACY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMPLANTATION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOSA INFLAMMATION;

EID: 0034834903     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17500     Document Type: Article

References (141)

1. The changing epidemiology of bacteremia in neutropenic children with cancer
2. Infection control during gastrointestinal endoskopy. Guidelines for clinical application
3. Penicillin-resistant Streptococcus mitis as a cause of septicemia with meningitis in febrile neutropenic children
4. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients
5. Predisposing conditions and pathogens in bacteremia in hospitalized children
6. Bakteriämie-episoden bei pädiatrisch onkologischen patienten, insbesondere durch streptokokken der viridans-gruppe
7. Antimikrobielle therapie
8. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
9. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy
10. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia
11. A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients
12. Long-term use of indwelling multipurpose silastic catheters in pediatric cancer patients treated with aggressive chemotherapy
13. Prophylaxis of streptococcal bacteremia with oral penicillin V in children undergoing bone marrow transplantation
14. Infectious complications of patients undergoing therapy for acute leukemia: Current status and future prospects
15. Fungal infection ofventriculoperitoneal shunts in children
16. Prophylactic cotrimoxazole vs. norfloxacin in neutropenic children: Prospective randomized study
17. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis
18. Prevention of indwelling central venous catheter sepsis
19. Emergence of resistance during selective decontamination of the digestive tract
20. Quality standard for antimicrobial prophylaxis in surgical procedures
21. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients
22. Evidenzbasierte empfehlungen zur perioperativen antibioticaprophylaxe
23. Bacterial resistance and overgrowth due to selective decontamination of the digestive tract
24. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German University Pediatric Hospital
25. Septicemia and shock syndrome due to viridans streptococci: A Case Control Study of Predisposing Factors
26. Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis
27. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs. ciprofloxacin plus amoxicillin
28. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia
29. Oral anti-microbial prophylaxis in bone marrow transplant recipients: Randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin
30. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients
31. Clostridium difficile-associated diarrhea and colitis
32. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
33. A review of the role of antibiotic policies in the control of antibiotic resistance
34. Rifampicin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: Results of a randomized clinical trial
35. Die antiinfektiöse prophylaxe in der padiatrischen onkologie
36. Vancomycin resistant enterococci: Impact and management in pediatrics
37. Respiratory failure elicited by streptococcal septicemia in patients with cytosine arabinoside, and its prevention by penicillin
38. Prevention of viridans-group streptococcal septicemia in oncohematologic patients: A controlled comparative study on the effect of penicillin G and cotrimoxazole
39. Selective decontamination in bone marrow transplant recipients
40. Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders
41. Atraumatische clostridium septicum infektion bei granulozytopenie
42. Randomized placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus
43. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection
44. Primary cutaneous bacillus cereus infection in neutropenic children
45. Vancomycin use in pediatric hematology-oncology patients
46. Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive Bacteremia
47. Recommendations for preventing the spread of vancomycin resistance
48. Successful chemoprophylaxis for pneumocystis carinii pneumonitis
49. Successful intermittent chemoprophylaxis for pneumocystis carinii pneumonitis
50. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
51. Trimethoprim and sulfonamide resistance
52. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: Ciprofloxacin versus co-trimoxazole
53. Antimicrobial prophylaxis in neurosurgery and after head injury
54. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin
55. Anti-streptococcal activity of SB-265 805 (LB 20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines
56. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia
57. Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus
58. Streptococcal Bacteremia in adult patients with leukemia undergoing aggressive chemotherapy: A review of 55 cases
59. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center
60. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis
61. The prophylaxis of bacterial infections in neutropenic patients
62. Alcalagines xylosoxidans subsp. xylosoxidans in neutropenic patients
63. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin
64. Stenotrophomonas maltophilia Bacteremia in cancer patients: Report on 31 cases
65. Severe bactrim-induced neutropenia with reversal of CD4 +/CD8 + lymphocyte ratio: Response to recombinant human granulocyte-colony stimulating factor (R-metHUG-CSF)
66. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteriaemia during antimicrobial prophylaxis: A case-control study
67. Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: A prospective randomized trial among 59 patients
68. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: Meta-analysis
69. A prospective study of gram-negative Bacteremia in children
70. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: A randomized, controlled trial
71. Medical Progress: Staphylococcus aureus infection
72. Control of antimicrobial resistance in the health care system
73. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?
74. Stomatococcus mucilaginosus: An Emerging pathogen in neutropenic patients
75. Cerebrospinal fluid shunt infections in children
76. Infection control and bone marrow transplantation
77. Nosocomial septicemia in the cancer patient: The influence of central venous access devices, neutropenia and type of malignancy
78. Vancomycin-resistant enterococcal infections
79. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: Risk factors of colonisation
80. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers
81. Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: Clonal analysis
82. Outbreak of coagulase-negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit
83. Safety of ciprofloxacin as a prophylactic agent for prevention of Bacteremia infections in pediatric bone marrow transplantat (BMT) patients
84. Use of fluoroquinolones as prophylactic agents in patients with neutropenia
85. Guideline for prevention of intravascular device-related infections
86. Outbreak of Pseudomonas cepacia in oncology patients
87. Investigation of an outbreak of gram-negative Bacteremia among hematology-oncology outpatients
88. Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in postchemotherapy agranulocytic patients
89. Increasing incidence of gram positive sepsis in cancer patients
90. The value of protective isolation in preventing nosocomial infections in high risk patients
91. Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient
92. Considerations for the prevention of infectious complications in patients with cancer
93. The child with cancer and infection. 1. Empiric therapy for fever and neutropenia, and preventive strategies
94. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high does chemotherapy and ciprofloxacin prophylaxis
95. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy
96. A randomised, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children
97. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients
98. Viridans streptococci in patients with neutropenia
99. Sepsis dutch vergrünende Streptokokken bei kindern mit malignen hämatologischen erkrankungen
100. Decreased incidence of viridans streptococcal septicemia in allogenic bone marrow transplant recipients after the introduction of acyclovir
101. Prevention of infection in the immuno-compromised host
102. Nosocomial colonization and infection caused by multiresistant Enterobacter cloacae strains in a pediatric oncology ward
103. Pediatric update: Acute myeloid leukaemias
104. Surveillance nosokomialer infektionen sowie die erfassung von erregern mit speziellen resistenzen und multiresistenzen § 6 Abs 3 und § 23 Abs 1 und 2 in verbindung mit § 4 Abs 2 Nr 2 IfSG rechtliche voraussetzungen und umsetzungsempfehlungen
105. Two case reports and review of vascular catheter-associated Bacteremia caused by nontuberculous Mycobacterium species
106. Necrotic soft-tissue lesion due to Corynebacterium urealyticum in a neutropenic child
107. Role of the new quinolones in pediatric practice
108. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: A randomized trial in neutropenic patients
109. Empiric Therapy with carbenicillin and gentamycin for febrile patients with cancer and granulocytopenia
110. Origin of infection in acute nonlymphocytic leukemia: Significance of hospital acquisition of potential pathogens
111. Infections in cancer patients: Some controversial issues
112. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogenic bone marrow transplantation
113. Vancomycin-resistant-enterococci - Colonisation of 24 Patients in a pediatric oncology unit
114. Emergence of vancomycin resistance in coagulase-negative staphylococci
115. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms
116. Prevention of infections in bone marrow transplant recipients
117. Vancomycin use in pediatric neurosurgery patients
118. Reducing the spread of antimicrobial-resistant microorganisms: Control of vancomycin-resistant enterococci
119. Society of healthcare epidemiology of america and infectious diseases society of america joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of resistance in hospitals
120. Clostridium-difficile-assoziierte Diarrhoe bei pädiatrischen Patienten - Vorkommen, Therapieindikationen und Behandlungsstrategie
121. Catheter-related bloodstream infections
122. The clinical impact of early gram-positive Bacteremia and the use of vancomycin after allogenic bone marrow transplantation
123. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with Vancomycin-susceptible organisms
124. Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma
125. Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial of vancomycin
126. Adverse reactions to co-trimoxazole in HIV infection
127. Colonisation resistance in the digestive tract in mice during systemic antibiotic treatment
128. Prevention of infection in the neutropenic patient
129. Prophylaxis and empiric therapy for streptococcal infections in febrile neutropenic patients
130. Colonisation resistance
131. Mycobacterial central venous catheter tunnel infection: A difficult problem
132. Trends in infection morbidity in a pediatric oncology ward, 1986-1995
133. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium
134. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia
135. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
136. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
137. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium
138. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria